345 related articles for article (PubMed ID: 22865455)
1. CD133+ melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry.
Lai CY; Schwartz BE; Hsu MY
Cancer Res; 2012 Oct; 72(19):5111-8. PubMed ID: 22865455
[TBL] [Abstract][Full Text] [Related]
2. VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth.
Frank NY; Schatton T; Kim S; Zhan Q; Wilson BJ; Ma J; Saab KR; Osherov V; Widlund HR; Gasser M; Waaga-Gasser AM; Kupper TS; Murphy GF; Frank MH
Cancer Res; 2011 Feb; 71(4):1474-85. PubMed ID: 21212411
[TBL] [Abstract][Full Text] [Related]
3. CD133+ glioblastoma stem-like cells induce vascular mimicry in vivo.
Chiao MT; Yang YC; Cheng WY; Shen CC; Ko JL
Curr Neurovasc Res; 2011 Aug; 8(3):210-9. PubMed ID: 21675958
[TBL] [Abstract][Full Text] [Related]
4. CD133 as a marker for regulation and potential for targeted therapies in glioblastoma multiforme.
Choy W; Nagasawa DT; Trang A; Thill K; Spasic M; Yang I
Neurosurg Clin N Am; 2012 Jul; 23(3):391-405. PubMed ID: 22748652
[TBL] [Abstract][Full Text] [Related]
5. Clonal dominance of CD133+ subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma.
Sharma BK; Manglik V; O'Connell M; Weeraratna A; McCarron EC; Broussard JN; Divito KA; Simbulan-Rosenthal CM; Rosenthal DS; Zapas JL
Int J Oncol; 2012 Nov; 41(5):1570-6. PubMed ID: 22922842
[TBL] [Abstract][Full Text] [Related]
6. Exploring stemness gene expression and vasculogenic mimicry capacity in well- and poorly-differentiated hepatocellular carcinoma cell lines.
Lirdprapamongkol K; Chiablaem K; Sila-Asna M; Surarit R; Bunyaratvej A; Svasti J
Biochem Biophys Res Commun; 2012 Jun; 422(3):429-35. PubMed ID: 22580004
[TBL] [Abstract][Full Text] [Related]
7. Identification of cells initiating human melanomas.
Schatton T; Murphy GF; Frank NY; Yamaura K; Waaga-Gasser AM; Gasser M; Zhan Q; Jordan S; Duncan LM; Weishaupt C; Fuhlbrigge RC; Kupper TS; Sayegh MH; Frank MH
Nature; 2008 Jan; 451(7176):345-9. PubMed ID: 18202660
[TBL] [Abstract][Full Text] [Related]
8. Induction of Vasculogenic Mimicry Overrides VEGF-A Silencing and Enriches Stem-like Cancer Cells in Melanoma.
Schnegg CI; Yang MH; Ghosh SK; Hsu MY
Cancer Res; 2015 Apr; 75(8):1682-90. PubMed ID: 25769726
[TBL] [Abstract][Full Text] [Related]
9. Molecular regulation of vasculogenic mimicry in human uveal melanoma cells: role of helix-loop-helix Id2 (inhibitor of DNA binding 2).
Su F; Li B; Wang J; Xu X; Ren R; Li L; Gao F; Liu X
Graefes Arch Clin Exp Ophthalmol; 2009 Mar; 247(3):411-9. PubMed ID: 19043732
[TBL] [Abstract][Full Text] [Related]
10. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.
Calcagno AM; Salcido CD; Gillet JP; Wu CP; Fostel JM; Mumau MD; Gottesman MM; Varticovski L; Ambudkar SV
J Natl Cancer Inst; 2010 Nov; 102(21):1637-52. PubMed ID: 20935265
[TBL] [Abstract][Full Text] [Related]
11. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential.
Monzani E; Facchetti F; Galmozzi E; Corsini E; Benetti A; Cavazzin C; Gritti A; Piccinini A; Porro D; Santinami M; Invernici G; Parati E; Alessandri G; La Porta CA
Eur J Cancer; 2007 Mar; 43(5):935-46. PubMed ID: 17320377
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD133 and other putative stem cell markers in uveal melanoma.
Thill M; Berna MJ; Grierson R; Reinhart I; Voelkel T; Piechaczek C; Galambos P; Jager MJ; Richard G; Lange C; Gehling UM
Melanoma Res; 2011 Oct; 21(5):405-16. PubMed ID: 21900792
[TBL] [Abstract][Full Text] [Related]
13. Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts.
Orecchia P; Conte R; Balza E; Pietra G; Mingari MC; Carnemolla B
Oncotarget; 2015 Nov; 6(35):37426-42. PubMed ID: 26460958
[TBL] [Abstract][Full Text] [Related]
14. Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.
Kryczek I; Liu S; Roh M; Vatan L; Szeliga W; Wei S; Banerjee M; Mao Y; Kotarski J; Wicha MS; Liu R; Zou W
Int J Cancer; 2012 Jan; 130(1):29-39. PubMed ID: 21480217
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of spheroid cells from human malignant melanoma cell line WM-266-4.
Na YR; Seok SH; Kim DJ; Han JH; Kim TH; Jung H; Lee BH; Park JH
Tumour Biol; 2009; 30(5-6):300-9. PubMed ID: 19940551
[TBL] [Abstract][Full Text] [Related]
16. Latexin inhibits the proliferation of CD133+ miapaca-2 pancreatic cancer stem-like cells.
Xue ZX; Zheng JH; Zheng ZQ; Cai JL; Ye XH; Wang C; Sun WJ; Zhou X; Lu MD; Li PH; Cai ZZ
World J Surg Oncol; 2014 Dec; 12():404. PubMed ID: 25551472
[TBL] [Abstract][Full Text] [Related]
17. The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cells.
Redmer T; Welte Y; Behrens D; Fichtner I; Przybilla D; Wruck W; Yaspo ML; Lehrach H; Schäfer R; Regenbrecht CR
PLoS One; 2014; 9(5):e92596. PubMed ID: 24799129
[TBL] [Abstract][Full Text] [Related]
18. Putative CD133+ melanoma cancer stem cells induce initial angiogenesis in vivo.
Zimmerer RM; Matthiesen P; Kreher F; Kampmann A; Spalthoff S; Jehn P; Bittermann G; Gellrich NC; Tavassol F
Microvasc Res; 2016 Mar; 104():46-54. PubMed ID: 26656667
[TBL] [Abstract][Full Text] [Related]
19. Type 1 collagen as a potential niche component for CD133-positive glioblastoma cells.
Motegi H; Kamoshima Y; Terasaka S; Kobayashi H; Houkin K
Neuropathology; 2014 Aug; 34(4):378-85. PubMed ID: 24673436
[TBL] [Abstract][Full Text] [Related]
20. Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells.
Chen KL; Pan F; Jiang H; Chen JF; Pei L; Xie FW; Liang HJ
Clin Exp Metastasis; 2011 Dec; 28(8):751-63. PubMed ID: 21750907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]